Biotech Finds Mid-Week Success After Meeting Primary Endpoint
May 28 2025 - 5:50PM
AllPennyStocks.com
A biotech company based out of Massachusetts
found a tremendous amount of success mid-week after the company
announced that the pivotal Phase 3 PIVOT-PO trial evaluating
tebipenem...
To read the full story on AllPennyStocks.com, click
here.
Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Jun 2025 to Jul 2025
Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Jul 2024 to Jul 2025